Search results
Results From The WOW.Com Content Network
The International Classification of Diseases for Oncology ( ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases. This classification is widely used by cancer registries . It is currently in its third revision (ICD-O-3).
The International Classification of Diseases, Clinical Modification (ICD-9-CM) was an adaptation created by the US National Center for Health Statistics (NCHS) and used in assigning diagnostic and procedure codes associated with inpatient, outpatient, and physician office utilization in the United States. The ICD-9-CM is based on the ICD-9 but ...
ICD-10 is the 10th revision of the International Classification of Diseases (ICD), a medical classification list by the World Health Organization (WHO). It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases. [ 1] Work on ICD-10 began in 1983, [ 2 ...
The Pittsburgh Cancer Institute was founded in 1985 under the direction of Ronald B. Herberman, MD. [3] [4] In 1990, the center earned NCI designation. [5] The Hillman Cancer Center was opened in 2002 and housed the clinical services for UPMC Cancer Centers and research facilities for the Pittsburgh Cancer Institute. [6]
Cancer treatment. A patient prepared for radiation therapy. Specialty. Oncology. ICD-10-PCS. 110000053. [ edit on Wikidata] Cancer treatments are a wide range of treatments available for the many different types of cancer, with each cancer type needing its own specific treatment. [ 1] Treatments can include surgery, chemotherapy, radiation ...
The following is a list of cancer types. Cancer is a group of diseases that involve abnormal increases in the number of cells , with the potential to invade or spread to other parts of the body. [ 1 ]
Oncology. Non-small-cell lung cancer ( NSCLC ), or non-small-cell lung carcinoma, is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). NSCLC accounts for about 85% of all lung cancers. [ 1][ 2][ 3] As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma.
The concept of grading of the tumors of the central nervous system, agreeing for such the regulation of the "progressiveness" of these neoplasias (from benign and localized tumors to malignant and infiltrating tumors), dates back to 1926 and was introduced by P. Bailey and H. Cushing, in the elaboration of what turned out the first systematic classification of gliomas.